Biotech

All Articles

ReNeuron leaving objective exchange after missing fundraising goal

.ReNeuron has signed up with the long listing of biotechs to leave behind London's goal stock market...

MBX files for IPO to take opposition to Ascendis into period 3

.MBX Biosciences has actually contributed to the recent spurt of IPO filings. The biotech, which fil...

FDA extends probing in to Lykos' MDMA trials: WSJ

.For Lykos Therapeutics and also the company's potential MDMA-assisted treatment for post-traumatic ...

Gene publisher Volume giving up 131 workers

.Simply days after gene publisher Volume Biosciences revealed unrevealed operational slices, a more ...

Repare gives up 25% of personnel as biotech stops preclinical R&ampD

.Repare Therapy is actually laying off a fourth of its own staff as the oncology biotech scales back...

J &amp J declare FDA authorization of $6.5 B autoimmune medication

.Johnson &amp Johnson has taken one more step towards understanding a yield on its $6.5 billion nipo...

Gain's stage 1 gain leads means to prove Parkinson's medication's worth

.Gain Rehabs has prepared its direct proving the efficiency of its Parkinson's ailment treatment fol...

Actinogen records brand new period 2 records to restore depression medication

.Actinogen Medical's chances-- and also sell cost-- have rebounded slightly from earlier this month,...

Pfizer and Flagship include Ratio to multibillion-dollar equation

.Flagship Pioneering and Pfizer have actually added Ratio right into their 10-program collaboration,...

Bayer pens $547M treaty to push boundaries of noncoding RNA

.Bayer executives were interested to worry to Ferocious this summer season that the German pharma ti...